In line with these findings, a microarray study from our group (Schulz et al, 2007) indicated significantly increased DKC1 expression in a subset of prostate cancers with a combination of molecular changes, that is, chromosome 8 alterations and LINE-1 hypomethylation, typical of advanced cases. This evidence concerns the gene DKC1 and Familial prostate cancer.